Between 2021 and 2022, Yum Yum Videos produced two custom explainer videos for BrightInsight, supporting its communication strategy during a key phase of growth. During that period, BrightInsight raised $101M in Series C funding, accelerated global expansion, and scaled its regulated digital health platform during a period that included Deloitte Fast 500 recognition and reported revenue growth.
BrightInsight featured the “Meet the BrightInsight Platform” explainer on its official blog on March 4, 2021.
Our collaboration with BrightInsight coincided with a period of accelerated growth and market expansion:
Throughout this pivotal growth stage, Yum Yum Videos helped BrightInsight communicate complex, regulated innovation with clarity and confidence — supporting fundraising, enterprise adoption, and global expansion.
BrightInsight is a regulated digital health platform that enables biopharma and medtech companies to build and scale compliant digital health solutions. Its value proposition is powerful but highly technical — requiring clear, precise communication to engage pharma partners, clinicians, and stakeholders within complex regulatory environments.
1. Simplify a highly regulated digital health platform for multiple audiences.
2. Attract innovation and compliance during key fundraising stages.
3. Support adoption and understanding across partners, clients, and clinical stakeholders.
To meet these needs, Yum Yum Videos created two custom explainer videos for BrightInsight between 2021 and 2022.
These focused on clearly introducing BrightInsight’s regulated digital health platform and explaining how its disease management solutions enable compliant innovation for biopharma and medtech companies. What began as a focused engagement resulted in core communication assets used to support fundraising conversations, partner education, and market understanding as the company scaled globally.
BrightInsight’s funding round and rapid growth were covered by leading global healthcare and business media outlets. From Mercom Capital Group to Bloomberg and industry publications, the company’s regulated digital health platform gained international visibility as it scaled across biopharma and medtech — with our explainer even featured visually in external coverage during this phase.
“Digital health platform BrightInsight raises $101M in Series C funding”
“BrightInsight raises $101M for its regulated digital health platform”
“BrightInsight Ranked #307 Fastest-Growing Company in North America (431% Growth)”
From strategy to execution, every detail was designed to turn complexity into clarity.
1. Clarity at scale – Regulated digital health concepts simplified into clear, visual stories.
2. Credibility – Design and tone reinforced trust in highly regulated environments.
3. Versatility – Used across fundraising, launches, and partner communications.
4. Strategic timing – Deployed during key growth and funding milestones.
Complex regulated health concepts were translated into clear, easy-to-follow visual stories.
Clean layouts, precise motion, and restrained visuals kept the focus on clarity and compliance.
BrightInsight’s brand palette was paired with neutral backgrounds to convey a modern, clinical, and trustworthy look.
Clear and authoritative, reinforcing credibility with investors, partners, and healthcare stakeholders.
